TXG
10x Genomics Inc Earnings
$10.69
Earnings Summary
Revenue | $165.02Mn |
Net Profits | $-49.03Mn |
Net Profit Margins | -29.71% |
10x Genomics Inc’s revenue fell -10.3% since last year same period to $165.02Mn in the Q4 2024. On a quarterly growth basis, 10x Genomics Inc has generated 8.81% jump in its revenue since last 3-months.
10x Genomics Inc’s net profit fell -0.16% since last year same period to $-49.03Mn in the Q4 2024. On a quarterly growth basis, 10x Genomics Inc has generated -37.13% fall in its net profits since last 3-months.
10x Genomics Inc’s net profit margin fell -11.66% since last year same period to -29.71% in the Q4 2024. On a quarterly growth basis, 10x Genomics Inc has generated -26.02% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.11 |
EPS Estimate Current Year | -0.11 |
10x Genomics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.11 - a 68.62% jump from last quarter’s estimates.
10x Genomics Inc’s earning per share (EPS) estimates for the current year stand at -0.11.
Key Ratios
Earning Per Share (EPS) | -0.14 |
10x Genomics Inc’s earning per share (EPS) jumped 66.93% since last year same period to -0.14 in the Q4 2024. This indicates that the 10x Genomics Inc has generated 66.93% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-08 | -0.48 | -0.32 | 33.33% |
2024-04-30 | -0.5 | -0.5 | 0% |
2025-02-13 | -0.11 | -0.14 | -27.09% |
2024-10-29 | -0.34 | -0.3 | 11.76% |
